-
S287393-5mgSerine/threonine protein kinase 16 (STK16) inhibitor also inhibits PI 3Kδ, PI 3Kγ and mTOR kinases
-
T287386-10mgPotent and selective PDE10A inhibitor
-
T287386-50mgPotent and selective PDE10A inhibitor
-
T287927-10mgPotent and selective Tpl2 (Cot MAP3K8) inhibitor
-
T287927-50mgPotent and selective Tpl2 (Cot MAP3K8) inhibitor
-
T287170-10mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM
-
T287170-1mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM
-
T287170-25mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM
-
T287170-50mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM
-
T287170-5mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM
-
T286898-10mgNSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3
-
T286898-50mgNSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3